The urgent need for nurse practitioners to slow antibiotic resistance and advance health equity through appropriate antibiotic prescribing

Affiliations

¹ Jefferson Center for Infection Prevention and Antibiotic Stewardship, Thomas Jefferson University, Jefferson College of Nursing Philadelphia, Pennsylvania.
² Cardiac Surgery Intensive Care Unit, Thomas Jefferson University, Jefferson College of Nursing, Philadelphia, Pennsylvania.
³ Department of Emergency Medicine, Thomas Jefferson University, Jefferson College of Nursing, Philadelphia, Pennsylvania.
⁴ Division of Infectious Diseases, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania.

Mary Lou Manning et al. J Am Assoc Nurse Pract. 2024.

. 2024 Feb 1;36(2):86-89.

doi: 10.1097/JXX.0000000000000981.

¹ Jefferson Center for Infection Prevention and Antibiotic Stewardship, Thomas Jefferson University, Jefferson College of Nursing Philadelphia, Pennsylvania.
² Cardiac Surgery Intensive Care Unit, Thomas Jefferson University, Jefferson College of Nursing, Philadelphia, Pennsylvania.
³ Department of Emergency Medicine, Thomas Jefferson University, Jefferson College of Nursing, Philadelphia, Pennsylvania.
⁴ Division of Infectious Diseases, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania.

No abstract available

Conflict of interest statement

Competing interests: The authors report no conflicts of interest.

1. American Association of Nurse Practitioners (AANP). (2022). NP Facts. NPFacts__111022.pdf . (aanp.org).
1. Centers for Disease Control and Prevention (CDC). (2019). Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services.
1. Centers for Disease Control and Prevention (CDC). (2022). Health equity and antibiotic resistance fact sheet. Health-Equity-Antibiotic-Resistance-FS-508.pdf . (cdc.gov).
1. Centers for Disease Control and Prevention (CDC). (2021). Outpatient antibiotic prescriptions — United States, 2021. Outpatient Antibiotic Prescriptions—United States, 2020 | Antibiotic Use | CDC.
1. Chalasani R., Krishnamurthy S., Suda K. J., Newman T. V., Delaney S. W., Essien U. R. (2022). Pursuing pharmacoequity: Determinants, drivers, and pathways to progress. Journal of Health Politics, Policy and Law, 47(6), 709–729. https://doi.org/10.1215/03616878-10041135 - DOI